Valuation: ARYA SCIE

Market Cap 5Cr 4.35Cr 4.04Cr 3.72Cr 7.01Cr 477.75Cr 7.14Cr 48Cr 19Cr 237.28Cr 19Cr 18Cr 797.94Cr P/E 2022
182x
P/E 2023 -50.1x
Enterprise Value 5.22Cr 4.53Cr 4.21Cr 3.88Cr 7.31Cr 498.32Cr 7.45Cr 50Cr 20Cr 247.49Cr 20Cr 19Cr 832.3Cr EV / Sales 2022
-
EV / Sales 2023 -
Free-Float
-
Yield 2022 *
-
Yield 2023 -
14/24/14 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
31/24/31 ARYA Sciences Acquisition Corp IV(NasdaqCM:ARYD) dropped from NASDAQ Composite Index CI
31/24/31 Adagio Medical, Inc. completed the acquisition of ARYA Sciences Acquisition Corp IV from a group of shareholders in a reverse merger transaction. CI
28/24/28 ARYA Sciences Acquisition Corp IV announced that it has received $0.15 million in funding from ARYA Sciences Holdings IV CI
21/24/21 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
29/24/29 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023 CI
08/24/08 ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV CI
10/23/10 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
27/23/27 ARYA Sciences Acquisition Corp IV announced that it has received $0.9 million in funding CI
12/23/12 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
02/23/02 ARYA Sciences Acquisition Corp IV announced that it has received $0.14 million in funding from ARYA Sciences Holdings IV CI
13/23/13 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
07/23/07 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2022 CI
1 day-8.66%
Current month-94.36%
Current year-94.36%
3 years 0.36
Extreme 0.363
11.57
5 years 0.36
Extreme 0.363
11.57
10 years 0.36
Extreme 0.363
12.38
Manager TitleAgeSince
Corporate Officer/Principal 42 01/01/2021
Director TitleAgeSince
Director/Board Member 55 25/02/2021

Financials

2022 2023
Net sales - -
Net income 10.67L 9L 9L 8L 14.96L 10Cr 15.23L 1.02Cr 39.91L 5.06Cr 40.09L 39.21L 17Cr -21.33L -18.53L -17.21L -15.87L -29.89L -20Cr -30.43L -2.04Cr -79.76L -10Cr -80.11L -78.36L -34Cr
Net Debt 0.03 0.03 0.02 0.02 0.04 2.76 0.04 0.28 0.11 1.37 0.11 0.11 4.62 2.15 1.87 1.74 1.6 3.02 205.72 3.07 20.58 8.06 102.17 8.09 7.91 343.59
Logo ARYA SCIE
ARYA Sciences Acquisition Corp IV is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is focused on healthcare or healthcare related industries. The Company has no operations and has not generated revenues.
Employees
-
Sector
-
Date Price Change Volume
30/26/30 $0.3745 -8.66% 1,19,999
29/26/29 $0.4100 -8.40% 88,121
28/26/28 $0.4476 -7.06% 2,16,239
27/26/27 $0.4816 -0.08% 28,411
24/26/24 $0.4820 -1.63% 1,33,653
  1. Stock Market
  2. Stocks
  3. ARYD Stock